Lazard Asset Management’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,116
| Closed | -$11K | – | 1831 |
|
|
2019
Q4 | $11K | Hold |
1,116
| – | – | ﹤0.01% | 1384 |
|
|
2019
Q3 | $11K | Buy |
+1,116
| New | +$11K | ﹤0.01% | 1301 |
|
|
2018
Q2 | – | Sell |
-78,034
| Closed | -$1.19M | – | 1153 |
|
|
2018
Q1 | $1.19M | Buy |
+78,034
| New | +$1.19M | ﹤0.01% | 692 |
|
|
2014
Q1 | – | Sell |
-32,350
| Closed | -$634K | – | 1082 |
|
|
2013
Q4 | $634K | Buy |
+32,350
| New | +$634K | ﹤0.01% | 740 |
|